• Corline Biomedical AB reported that Kardium secured up to CAD 31.25 million in Canadian government funding via the Strategic Response Fund.
• Funding targets a major expansion of manufacturing capacity for Kardium’s Globe system.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corline Biomedical AB published the original content used to generate this news brief on August 28, 2026, and is solely responsible for the information contained therein.